PDCD1 and Opportunistic infection: Both ICI treatments strongly improved morbidity and mortality of R. arrhizus-infected mice, adding to an increasing body of evidence pointing to the PD-1 immune checkpoint pathway as an appealing therapeutic target for opportunistic infections (12).